The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated

Firdevs Aysenur Ekizler1, Bahar Tekin Tak1, Serkan Cay1

  • 1Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Insights

The Fibrosis-4 (FIB-4) index can predict major arrhythmic events in patients with nonischemic dilated cardiomyopathy (NIDCM). This accessible marker helps identify high-risk individuals for closer monitoring and interventions.

Area of Science:

  • Cardiology
  • Biomarkers
  • Arrhythmology

Background:

  • Nonischemic dilated cardiomyopathy (NIDCM) poses challenges in identifying patients at risk for ventricular arrhythmias.
  • The Fibrosis-4 (FIB-4) index, a liver fibrosis marker, shows potential in cardiovascular risk assessment.
  • Current methods for risk stratification in NIDCM require further noninvasive tools.

Purpose of the Study:

  • To investigate the association between FIB-4 index levels and the risk of major arrhythmic events in NIDCM patients.
  • To determine if FIB-4 can serve as an independent predictor of adverse arrhythmic outcomes in this population.

Main Methods:

  • A cohort of 1233 NIDCM patients was evaluated.
  • The primary endpoint was a composite of sudden cardiac death, sustained ventricular tachycardia/fibrillation, or appropriate ICD therapy.
  • Follow-up was conducted for a median of 70 months.

Main Results:

  • The composite arrhythmic event occurred in 29.8% of patients during follow-up.
  • A FIB-4 cut-off of 1.67 demonstrated 66% sensitivity and 81% specificity for predicting the primary endpoint.
  • FIB-4 ≥ 1.67 was independently associated with increased arrhythmic risk (HR: 4.88, p < 0.001) after multivariate analysis.

Conclusions:

  • The FIB-4 index is an independent predictor of major arrhythmic events and mortality in NIDCM patients.
  • The readily available FIB-4 index can aid in identifying high-risk NIDCM patients.
  • FIB-4 may guide closer monitoring or prophylactic interventions for at-risk individuals.
Abstract

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...